Loading…
Orchid Pharma (ORCHPHARMA)₹884.00−0.29%Pharmaceuticals
At the end of the Jun 2026 quarter, Orchid Pharma's shareholders were: promoters 69.88%, FIIs 0.80%, DIIs 20.74%, public 8.58%. Promoter holding is unchanged on the quarter. FII holding is down 0.60 percentage points from 1.40% a year earlier. It had 33,439 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 72.44% | 69.88% | 69.88% | 69.88% | 69.88% | 69.88% | 69.88% | 69.88% | 69.88% | 69.88% | 69.88% | 69.88% |
| FIIs | 8.09% | 4.15% | 1.97% | 1.43% | 1.95% | 2.54% | 2.70% | 1.40% | 1.57% | 1.18% | 0.87% | 0.80% |
| DIIs | 12.45% | 14.50% | 17.72% | 18.92% | 18.29% | 18.99% | 20.09% | 19.42% | 19.03% | 19.37% | 20.23% | 20.74% |
| Public | 7.02% | 11.47% | 10.43% | 9.77% | 9.88% | 8.59% | 7.33% | 9.30% | 9.52% | 9.57% | 9.02% | 8.58% |
| Number of shareholders | 29,202 | 36,938 | 36,727 | 34,701 | 36,369 | 34,164 | 34,309 | 39,834 | 38,162 | 35,715 | 35,124 | 33,439 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Dhanuka Laboratories Limited | Promoter | 69.82% | 0.00 |
| Quant Mutual Fund - Quant Small Cap Fund | DII | 6.80% | 0.00 |
| Kotak Mahindra Trustee Co Ltd A/C Kotak Consumption Fund And 7 Others | DII | 4.62% | New |
| Uti Small Cap Fund And 3 Others | DII | 3.47% | New |
| Invesco India Contra Fund And 2 Others | DII | 2.86% | New |
| Bandhan Small Cap Fund And 5 Others | DII | 1.52% | New |
| Kotak Mahindra Trustee Co Ltd A/C Kotak Multi Asset Allocation Fund And 5 Others | DII | Exited | — |
| Uti-Healthcare Fund And 3 Others | DII | Exited | — |
| Invesco India Equity Savings Fund And 2 Others | DII | Exited | — |
| Bandhan Bse Healthcare Index Fund And 3 Others | DII | Exited | — |
Promoters held 69.88% of Orchid Pharma at the end of the Jun 2026 quarter, the same as a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 0.80% (down 0.07 percentage points from 0.87% a quarter earlier) and domestic institutions (DIIs) held 20.74% (up 0.51 percentage points from 20.23% a quarter earlier).
Orchid Pharma had 33,439 shareholders at the end of the Jun 2026 quarter, against 39,834 a year earlier.
Quant Mutual Fund - Quant Small Cap Fund (DII) held 6.80% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.